Premium
The use of neuromuscular blocking agents in noncardiac surgery after dynamic cardiomyoplasty
Author(s) -
J. A. B. Timmerman,
Joost M. van der Maaten,
J. M. K. H. Wierda,
A. A. Broekema,
Hubert E. Mungroop,
Marlies Brouwer,
Maarten P. van den Berg
Publication year - 1999
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1046/j.1365-2044.1999.00963.x
Subject(s) - medicine , cardiomyoplasty , rocuronium , neuromuscular blocking agents , anesthesia , latissimus dorsi muscle , cardiology , surgery , heart failure , propofol
Dynamic cardiomyoplasty is a surgical treatment to improve cardiac performance in patients with end‐stage heart failure by wrapping the latissimus dorsi muscle around the heart. The use of skeletal muscle raises concerns about the safety of neuromuscular blocking agents used during general anaesthesia in noncardiac surgery in patients after cardiomyoplasty. We describe the administration of rocuronium to a patient undergoing carotid endarterectomy 18 months after cardiomyoplasty. No clinically relevant effects on haemodynamics were observed. We conclude that the use of nondepolarising neuromuscular blocking agents for noncardiac surgery in patients after cardiomyoplasty does not compromise cardiac performance in a clinically relevant way, although the time between the cardiomyoplasty procedure and the use of nondepolarising neuromuscular blocking agents remains a concern.